Amino Terminal Pro–B-Type Natriuretic Peptide, Secondary Stroke Prevention, and Choice of Antithrombotic Therapy

MLA

Christopher DeFilippi, et al. “Amino Terminal Pro–B-Type Natriuretic Peptide, Secondary Stroke Prevention, and Choice of Antithrombotic Therapy.” Stroke, vol. 44, Mar. 2013, pp. 714–19. EBSCOhost, https://doi.org/10.1161/strokeaha.112.675942.

APA

Christopher DeFilippi, Robin L. Brey, Rebecca Gross, John L.P. Thompson, Robert H. Christenson, William T. Longstreth, David L. Tirschwell, Richard A. Kronmal, Stephen L. Seliger, Richard Buchsbaum, Steven R. Levine, Jay P. Mohr, & Mitchell S.V. Elkind. (2013). Amino Terminal Pro–B-Type Natriuretic Peptide, Secondary Stroke Prevention, and Choice of Antithrombotic Therapy. Stroke, 44, 714–719. https://doi.org/10.1161/strokeaha.112.675942

Chicago

Christopher DeFilippi, Robin L. Brey, Rebecca Gross, John L.P. Thompson, Robert H. Christenson, William T. Longstreth, David L. Tirschwell, et al. 2013. “Amino Terminal Pro–B-Type Natriuretic Peptide, Secondary Stroke Prevention, and Choice of Antithrombotic Therapy.” Stroke 44 (March): 714–19. doi:10.1161/strokeaha.112.675942.